Literature DB >> 21103004

Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets.

Dongping Wei1, Yi Sun.   

Abstract

The SCF (Skp1-cullin-F-box proteins), also known as CRL (cullin-based RING ligase), is the largest family of E3 ubiquitin ligases that mediate approximately 20% ubiquitinated protein substrates for 26S proteasome degradation. Through promoting timely degradation of many key regulatory proteins, SCF E3 ligase controls numerous cellular processes; its dysfunction contributes to a number of human diseases, including cancer. The RING component of SCF complex consists of 2 family members, RBX1 (RING box protein 1), also known as ROC1 (regulator of cullins), and RBX2/ROC2 (also known as SAG [sensitive to apoptosis gene]), both of which are essential for the catalytic activity of SCF. RBX1 and RBX2 are evolutionarily conserved from yeast to humans and play an essential role during mouse embryonic development. Moreover, RBX1 and RBX2 are both overexpressed in multiple human cancer tissues and required for the growth and survival of cancer cells. In this review, we will discuss the similarities and differences between 2 RING family members, their regulation of SCF E3 ligase activity, and their role in development, cancer cell survival, and skin carcinogenesis, along with a brief discussion of RBX-SCF E3 ligases as the cancer targets and a recently discovered small molecule inhibitor of SCF E3 ligases as a novel class of anticancer drugs.

Entities:  

Keywords:  RING box proteins; SCF E3 ubiquitin ligases; anticancer targets; neddylation; protein degradation; ubiquitin-proteasome system

Year:  2010        PMID: 21103004      PMCID: PMC2983490          DOI: 10.1177/1947601910382776

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  99 in total

1.  Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.

Authors:  Hui-Kuan Lin; Zhenbang Chen; Guocan Wang; Caterina Nardella; Szu-Wei Lee; Chia-Hsin Chan; Chan-Hsin Chan; Wei-Lei Yang; Jing Wang; Ainara Egia; Keiichi I Nakayama; Carlos Cordon-Cardo; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-03-18       Impact factor: 49.962

2.  The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2.

Authors:  T Kamura; M N Conrad; Q Yan; R C Conaway; J W Conaway
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

3.  Targeted disruption of Drosophila Roc1b reveals functional differences in the Roc subunit of Cullin-dependent E3 ubiquitin ligases.

Authors:  Timothy D Donaldson; Maher A Noureddine; Patrick J Reynolds; William Bradford; Robert J Duronio
Journal:  Mol Biol Cell       Date:  2004-08-25       Impact factor: 4.138

4.  Regulation of nitric oxide-induced apoptosis by sensitive to apoptosis gene protein.

Authors:  Eun Sun Yang; Jeen-Woo Park
Journal:  Free Radic Res       Date:  2006-03

5.  A new NEDD8-ligating system for cullin-4A.

Authors:  F Osaka; H Kawasaki; N Aida; M Saeki; T Chiba; S Kawashima; K Tanaka; S Kato
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

Review 6.  Novel substrates and functions for the ubiquitin-like molecule NEDD8.

Authors:  Dimitris P Xirodimas
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

Review 7.  The role of ubiquitin in NF-kappaB regulatory pathways.

Authors:  Brian Skaug; Xiaomo Jiang; Zhijian J Chen
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

8.  Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.

Authors:  Teresa A Soucy; Peter G Smith; Mark Rolfe
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

9.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

10.  Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1's C-terminal tail.

Authors:  Kosj Yamoah; Taiji Oashi; Antonio Sarikas; Stefan Gazdoiu; Roman Osman; Zhen-Qiang Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

View more
  47 in total

1.  Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.

Authors:  Dongping Wei; Hua Li; Jie Yu; Jonathan T Sebolt; Lili Zhao; Theodore S Lawrence; Peter G Smith; Meredith A Morgan; Yi Sun
Journal:  Cancer Res       Date:  2011-11-09       Impact factor: 12.701

2.  Arsenite Targets the RING Finger Domain of Rbx1 E3 Ubiquitin Ligase to Inhibit Proteasome-Mediated Degradation of Nrf2.

Authors:  Ji Jiang; Lok Ming Tam; Pengcheng Wang; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2018-04-23       Impact factor: 3.739

Review 3.  Cell regulation by phosphotyrosine-targeted ubiquitin ligases.

Authors:  Jonathan A Cooper; Tomonori Kaneko; Shawn S C Li
Journal:  Mol Cell Biol       Date:  2015-03-16       Impact factor: 4.272

4.  Induction of cell senescence by targeting to Cullin-RING Ligases (CRLs) for effective cancer therapy.

Authors:  Yongfu Pan; Hua Xu; Rujiao Liu; Lijun Jia
Journal:  Int J Biochem Mol Biol       Date:  2012-09-25

Review 5.  A CULLINary ride across the secretory pathway: more than just secretion.

Authors:  Albert Lu; Suzanne R Pfeffer
Journal:  Trends Cell Biol       Date:  2014-03-11       Impact factor: 20.808

6.  Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.

Authors:  Hua Li; Mingjia Tan; Lijun Jia; Dongping Wei; Yongchao Zhao; Guoan Chen; Jie Xu; Lili Zhao; Dafydd Thomas; David G Beer; Yi Sun
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

7.  Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.

Authors:  Dongping Wei; Meredith A Morgan; Yi Sun
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

Review 8.  Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.

Authors:  Chuan-Ming Xie; Wenyi Wei; Yi Sun
Journal:  J Genet Genomics       Date:  2013-02-10       Impact factor: 4.275

Review 9.  Cullin-RING Ligases as attractive anti-cancer targets.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Rational discovery of molecular glue degraders via scalable chemical profiling.

Authors:  Sophie Bauer; Matthias Brand; Cristina Mayor-Ruiz; Zuzanna Kozicka; Marton Siklos; Hana Imrichova; Ines H Kaltheuner; Elisa Hahn; Kristina Seiler; Anna Koren; Georg Petzold; Michaela Fellner; Christoph Bock; André C Müller; Johannes Zuber; Matthias Geyer; Nicolas H Thomä; Stefan Kubicek; Georg E Winter
Journal:  Nat Chem Biol       Date:  2020-08-03       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.